Clinical Trials · NCT00930644
Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS)
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Shire
- Enrollment
- 88
- Start date
- Sep 2009
- Locations
- 23 sites, 9 countries
- Primary endpoint
- Percent Change in PN/IV Volume by Visit